biologit Articles

From Data to Evidence: March 2024 Biologit Newsletter

Welcome to From Data to Evidence, our newsletter with the latest industry and regulatory news in pharmacovigilance and technology

Case Study: Comprehensive Data Sources for High Quality Literature Monitoring

Literature search of safety events for Olutasidenib using the biologit Database

Compliant Literature Searches in Clinical Development: CAR T-Cell Case Study

For biotech and pharmaceutical companies with a clinical development program, understanding the safety and efficacy of a therapy is a key...

Literature Databases for Regulatory Searches

Regulatory Literature Searches for Safety Information Monitoring the scientific literature is critical component in understanding the...

FDA Compliant Literature Monitoring for Clinical Development

How to stay compliant with FDA literature requirements? Learn more in our guide.

Medical Literature Monitoring Automation

Challenges in Pharmacovigilance Literature Monitoring With the large and growing volume of scientific literature available, automating...

AI Risk Management: Approaches and Benefits

Risk management is one of the most valuable quality processes to ensure the continuous improvement of the biologit platform.

Feature Spotlight: Duplicate Detection in biologit MLM-AI Platform

In this article, we delve into the impact of duplicates in literature searches and introduce the automatic duplicate detection in Biologit M

Feature Spotlight: Teams Work Together in biologit MLM-AI

biologit MLM-AI is a literature monitoring platform that makes it easy for safety surveillance teams of all sizes to work together and...